Patent details

Basic Information

Publication number:

EP2458992

PCT Application Number:

PCT/US/2010/002129

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP108048265

PCT Publication Number:

WO/2011/014255

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF CROHN'S DISEASE WITH LAQUINIMOD

French Title of Invention:

TRAITEMENT DE LA MALADIE DE CROHN AU MOYEN DE LAQUINIMOD

German Title of Invention:

BEHANDLUNG VON MORBUS CROHN MIT LAQUINIMOD

SPC Number:

Dates

Filing date:

29/07/2010

Grant date:

16/12/2015

EP Publication Date:

16/12/2015

PCT Publication Date:

03/02/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/06/2012

EP B1 Publication Date:

16/12/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/07/2018

Expiration date:

29/07/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/07/2010

 

 

Name:

Teva Pharmaceutical Industries Ltd.

Address:

5 Basel Street P.O. Box 3190, 49131 Petach-Tikva, Israel (IL)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

03/02/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

TARCIC Nora

Address:

Israel (IL)

2

Name:

HAVIV Asi

Address:

Israel (IL)

3

Name:

BLAUGRUND Eran

Address:

Israel (IL)

4

Name:

KAYE Joel

Address:

Israel (IL)

Priority

Priority Number:

273167 P

Priority Date:

30/07/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4704;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

19/07/2017

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages
30/11/2018	Outgoing Correspondence	1